Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesPing An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd.

Consumer Cyclical Textile Manufacturing
PortfolioPortfolio WatchlistWatchlist
Company price
1.31 USD -0.28 ( 17.61%)
Last update at 2026-11-06T21:11:00Z
VOLUME
155971
Market Cap
16.60M

Momentum Score

…

Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services. The company serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. It was formerly known as Majestic Ideal Holdings Ltd. and changed its name to Ping An Biomedical Co., Ltd. in September 2025. The company was founded in 2013 and is based in Cheung Sha Wan, Hong Kong. Ping An Biomedical Co., Ltd. operates as a subsidiary of Action Holdings Limited.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
1.07
Low
1.75
High
52 Week Price Range
0.11
Low
1.39
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Ping An Biomedical Co., Ltd. is a Nasdaq-listed Chinese biomedical company that identifies itself as engaged in biomedical research, development and related services. Long-term growth drivers that could support the business include rising healthcare spending in China, demographic aging, and broader biotech innovation, which may benefit investors seeking exposure to the country's life‑sciences sector.

Material risks include limited public disclosure and reporting transparency, significant regulatory and clinical development uncertainty common to biomedical firms, and potential financing and market-competition pressures.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
1.59
Dividend Yield
-
Revenue TTM
25.51M
Revenue Per Share
0.73
Gross Profit TTM
2.37M
Debt / Equity
0.23
ROE
-11.35%
Net Debt
9.30M
ROCE
-31.71%
Diluted EPS TTM
-0.06

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax -14.68M -0.68M 0.04M 9.63M 7.82M
Net income -12.83M -1.28M -0.99M 7.23M 5.21M
Selling general administrative 6.00M 4.54M 2.88M 2.76M 2.93M
Selling and marketing expenses 0.30M 0.31M 0.33M 0.35M 0.44M
Gross profit 0.95M 5.42M 4.24M 14.14M 14.27M
Reconciled depreciation 0.01M 0.01M 0.03M 0.02M 0.39M
Ebit -14.38M 0.02M 1.78M 11.19M 9.18M
Ebitda -14.37M 0.47M 2.20M 11.61M 9.57M
Depreciation and amortization 0.01M 0.45M 0.42M 0.41M 0.39M
Operating income -14.70M -0.00M 0.61M 10.82M 8.27M
Other operating expenses 48.85M 87.62M 81.95M 103.73M 91.25M
Interest expense 0.31M 0.71M 1.74M 1.57M 1.36M
Tax provision -1.86M 0.60M 1.04M 2.40M 2.61M
Interest income 0.33M 0.00M 0.16M 0.04M 0.00M
Net interest income 0.02M -0.70M -1.58M -1.52M -1.36M
Income tax expense -1.86M 0.60M 1.04M 2.40M 2.61M
Total revenue 34.15M 87.62M 82.56M 114.55M 99.52M
Total operating expenses 15.65M 5.42M 3.63M 3.33M 6.00M
Cost of revenue 33.20M 82.21M 78.32M 100.40M 85.25M
Total other income expense net 0.02M -0.68M -0.57M -1.19M -0.45M
Net income from continuing ops -12.83M -1.28M -0.99M 7.23M 5.21M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 68.41M 56.85M 79.84M 81.95M 73.71M
Other current assets 44.84M 12.53M 11.74M 5.69M 4.47M
Total liab 23.17M 64.04M 85.70M 77.35M 75.77M
Total stockholder equity 45.24M -7.19M -5.86M 4.60M -2.06M
Other current liab 3.00M 35.82M 32.33M 20.94M 37.34M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings -21.05M -8.22M -6.58M 4.45M -2.07M
Cash 1.17M 0.13M 0.59M 1.17M 0.11M
Total current liabilities 23.08M 63.58M 85.63M 77.35M 75.70M
Current deferred revenue 0.07M 1.67M 0.53M 0.27M 1.67M
Net debt 9.30M 10.68M 42.36M 34.40M 28.85M
Short term debt 10.37M 10.35M 42.89M 35.57M 28.89M
Short long term debt 10.00M 10.00M 42.50M 35.50M 28.50M
Short long term debt total 10.47M 10.81M 42.96M 35.57M 28.96M
Other stockholder equity 66.21M - - - -0.01M
Total current assets 63.70M 53.31M 76.57M 79.04M 70.36M
Net receivables 17.25M 40.52M 61.05M 67.56M 49.78M
Inventory 0.44M 0.13M 3.19M 4.63M 16.01M
Accounts payable 9.41M 15.06M 9.27M 18.04M 7.14M
Accumulated other comprehensive income 0.07M 1.02M 0.71M 0.14M 0.01M
Non current assets total 4.72M 3.54M 3.27M 2.91M 3.34M
Capital lease obligations 0.47M 0.81M 0.46M 0.07M 0.46M
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments - 15.00M -3.37M -30.26M -0.03M
Total cashflows from investing activities - 15.00M -3.37M -30.26M -0.03M
Net borrowings -33.47M -29.77M 18.48M 15.06M 6.13M
Total cash from financing activities 43.66M -30.09M 8.87M 10.24M 31.45M
Net income -12.83M -1.28M -0.99M 7.23M 5.21M
Change in cash 36.57M -0.46M -0.57M 1.06M -0.05M
Begin period cash flow 0.13M 0.59M 1.17M 0.11M 0.16M
End period cash flow 36.70M 0.13M 0.59M 1.17M 0.11M
Total cash from operating activities -6.43M 14.63M -6.08M 21.09M -31.37M
Issuance of capital stock 108.19M 0.00M 0.00M 0.01M 0.00M
Depreciation 0.01M 0.01M 0.03M 0.02M 0.39M
Other cashflows from investing activities - 15.00M -3.37M -30.23M -
Dividends paid 0.00M 0.32M 9.60M 4.83M 0.00M
Change to inventory -0.31M 3.06M 1.44M 11.39M -10.18M
Change to account receivables 14.18M 6.53M 9.88M -7.79M -28.89M
Other cashflows from financing activities -31.06M - - - 25.32M
Capital expenditures 0.00M 0.00M 0.00M 0.02M 0.03M
Change in working capital -1.41M 15.77M -5.14M 13.98M -38.66M
Other non cash items 9.34M 0.13M 0.03M -0.19M 2.24M
Free cash flow -6.43M 14.63M -6.08M 21.06M -31.40M

Peer Comparison*

Sector: Consumer Cyclical Industry: Textile Manufacturing

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
PASW
Ping An Biomedical Co., Ltd.		 -0.28
17.61%		 1.31 - - 0.65 1.47 4.63 423.87
TRYIY
Toray Industries Inc ADR		 -0.37
2.38%		 15.10 22.91 111.11 0.00 0.97 0.94 9.34
SZHIF
Shenzhou International Group Holdings Limited		 -
-%		 6.78 13.40 11.40 0.38 1.84 1.36 4.96
SHZHY
Shenzhou International Group Holdings Limited		 0.19
3.63%		 5.42 8.09 9.09 0.22 1.26 1.05 3.82
CGGGF
Coats Group plc		 -
-%		 1.13 16.71 11.30 1.61 3.13 2.15 9.98

Profile*

Ping An Biomedical Co., Ltd.

Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services. The company serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. It was formerly known as Majestic Ideal Holdings Ltd. and changed its name to Ping An Biomedical Co., Ltd. in September 2025. The company was founded in 2013 and is based in Cheung Sha Wan, Hong Kong. Ping An Biomedical Co., Ltd. operates as a subsidiary of Action Holdings Limited.

China United Plaza, Cheung Sha Wan, Hong Kong

852 3915 2600

https://newbrandcashmere.com

7

Name Title Year Born
Mr. Pijun Liu CEO & Executive Chairman 1982
Mr. Sek Yan Ko Co-Founder & GM 1960
Ms. Hongli Yang Chief Financial Officer 1995

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…